Uncommon Therapeutics
ActiveA Disease Focused Biotech, Building Multiple Billion Dollar Drugs
What it does
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Next to it in Healthcare and bio · Gene therapy for genetic diseases
- Omnispirant LimitedPlug and Play PnP 2025
OmniSpirant develops regenerative gene therapies with game changing innovation in respiratory medicine and oncology.
- Restore VisionTechstars TS 2022
株式会社レストアビジョン
- Nuntius TherapeuticsY Combinator W21
Cell-specific genetic medicines
- NanograbY Combinator S23
Deliver genes to any cell with AI
- Modulari-TY Combinator W23
We teach your immune system to attack and cure cancer
- 株式会社センノ・セラピューティクスPlug and Play PnP 2026
ヒトiPS細胞由来の肝前駆細胞を活用した急性肝不全に対する細胞治療の開発
- Engage BioY Combinator W22
Potent, durable, and redosable non-viral genetic medicines
- Ameen500 Global 500G Mena 2
Provider of home physiotherapy services intended to reduce pain and improve physical health. The company provides physiotherapy of bones and muscles, neurology, athletes and pediatric physiotherapy, enabling patients to have physical therapy at their home.